Risk assessment of endocrine disruptors in nuclear receptors by means of antibody-sensing method to measure the conformation change associated with ligand binding

通过抗体传感方法测量与配体结合相关的构象变化,对核受体中的内分泌干扰物进行风险评估

基本信息

  • 批准号:
    16310044
  • 负责人:
  • 金额:
    $ 9.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2006
  • 项目状态:
    已结题

项目摘要

The chemicals acknowledged as endocrine-disruptors are believed to perturb an endocrine hormone system mainly by binding to the estrogen receptor (ER) and/or androgen receptor (AR). The human genome project revealed that there are 48 different kinds of nuclear receptors (NRs) in human. Endocrine disruptors are feasible to bind to all of these NRs, and thus these NRs should be examined for the influence of such chemicals. Preparing 'conformation change-sensing antibodies' that distinguish the active and inactive conformations of NRs, we have developed an assay methodology to estimate the receptor binding ability and activation capability of chemicals. This mehod is based on the amount of conformation change induced by ligand binding that causes a change of the NR from inactive apo conformation to active holo conformation. In the present study, we attempted to develop this methodology to all of 48 NRs.Mainly focusing on group III steroid hormone receptors, we first analyzed 48 human NRs by means of the method established as the 'quantitative evolutionary trace analysis' especially to explore the structure-function relationships. The analyses clearly revealed that there are two distinct types of NRs. One type is in a usual ligand-induced activation mechanism, while the other is in a spontaneous 'self-activation' mechanism. Estrogen-related receptor γ (ERR_γ) of the latter mechanism has shown that it binds specifically bisphenol A (BPA), a putative member of endocrine disruptors. Although BPA has been believed to bind to ER and AR, ERR_γ was found to be a BPA's true receptor. We succeeded in development of a novel conformation-change sensing assay method, which is applicable to even a self-activation type of NRs. The present study has led to significant fruitful results such as the discovery of self-activation type of NRs and ERR_γ as the receptor of an endocrine disruptor BPA.
被认为是内分泌干扰物的化学品主要通过与雌激素受体(ER)和/或雄激素受体(AR)结合来扰乱内分泌激素系统。人类基因组计划发现,人类有48种不同的核受体。内分泌干扰物可与所有这些NR结合,因此应检查这些NR是否受此类化学品的影响。制备区分NR的活性和非活性构象的“构象变化传感抗体”,我们已经开发了一种测定方法来估计化学品的受体结合能力和活化能力。该方法基于配体结合诱导的构象变化的量,所述构象变化导致NR从非活性脱辅基构象变化为活性全构象。在本研究中,我们尝试将这一方法应用于所有48个核受体,主要针对III组类固醇激素受体,首先利用建立的“定量进化痕迹分析”方法对48个人类核受体进行了分析,特别是探讨了结构与功能的关系。分析清楚地表明,有两种不同类型的NR。一种是在通常的配体诱导的激活机制,而另一种是在自发的“自激活”机制。雌激素相关受体γ(ERR_γ)与内分泌干扰物双酚A(BPA)特异性结合。虽然BPA被认为与ER和AR结合,但ERR_γ被发现是BPA的真正受体。我们成功地开发了一种新的构象变化传感检测方法,该方法甚至适用于自激活类型的NR。本研究取得了一些重要成果,如发现了自激活型NR和ERR_γ作为内分泌干扰物BPA的受体。

项目成果

期刊论文数量(43)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ligand-inducing conformation changes in the estrogen receptor C-terminal tail moiety and their sensing by polyclonal antibodies
雌激素受体 C 末端尾部部分的配体诱导构象变化及其多克隆抗体的传感
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shibuya;A.
  • 通讯作者:
    A.
Ligand-inducing conformation changes in the estrogen receptor C-terminal tail moiety and their sensing by polyclonal antibodies.
雌激素受体 C 末端尾部部分的配体诱导构象变化及其通过多克隆抗体的传感。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shibuya;A.;Koizumi;O.;Shimohigashi;Y
  • 通讯作者:
    Y
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIMOHIGASHI Yasuyuki其他文献

SHIMOHIGASHI Yasuyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIMOHIGASHI Yasuyuki', 18)}}的其他基金

Nuclear receptor-mediated bisphenol endocrine disrupting signal toxicity
核受体介导的双酚内分泌干扰信号毒性
  • 批准号:
    15H01741
  • 财政年份:
    2015
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Invention of superagonists and superantagonists for ORL1 nociceptin receptor
ORL1伤害感受素受体的超级激动剂和超级拮抗剂的发明
  • 批准号:
    23657078
  • 财政年份:
    2011
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Signal toxicity mediated through nuclear receptors of new generation bisphenols
通过新一代双酚核受体介导的信号毒性
  • 批准号:
    22221005
  • 财政年份:
    2010
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Elucidation of bisphenol A low-dose effects mediated through the nuclear receptor ERRγ
阐明双酚 A 通过核受体 ERRγ 介导的低剂量效应
  • 批准号:
    19201012
  • 财政年份:
    2007
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Novel Bioactive Conformation Constructed by Structurally Constrained CH/π Interaction between Amino Acids Side Chains
由氨基酸侧链之间结构约束的CH/π相互作用构建的新型生物活性构象
  • 批准号:
    10480152
  • 财政年份:
    1998
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Joint Study on Molecular Mechanism of Opioid Receptors
阿片受体分子机制联合研究
  • 批准号:
    09044230
  • 财政年份:
    1997
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Studies on the molecular mechanism of thrombin receptor activation by means of ligand peptides containing a series of fluorinated phenylalanines
含氟苯丙氨酸系列配体肽激活凝血酶受体的分子机制研究
  • 批准号:
    08458178
  • 财政年份:
    1996
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Investigation of Endocrine-Disrupting Chemicals as Contributors to Progression of Metabolic Dysfunction Associated Steatotic Liver Disease (EDC-MASLD)
内分泌干​​扰化学物质对代谢功能障碍相关脂肪性肝病 (EDC-MASLD) 进展的影响的调查
  • 批准号:
    10092670
  • 财政年份:
    2024
  • 资助金额:
    $ 9.92万
  • 项目类别:
    EU-Funded
Endocrine Disrupting Chemicals and Male-biased Neurobehavioral Disorders
内分泌干​​扰化学物质和男性神经行为障碍
  • 批准号:
    10561338
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
Understanding the Relationship Between Environmental Endocrine Disrupting Chemicals, Neuropsychiatric Outcomes, and Related Biological Processes in Depression
了解环境内分泌干扰化学物质、神经精神结果和抑郁症相关生物过程之间的关系
  • 批准号:
    10739590
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
A census of endocrine disrupting chemicals binding to nuclear receptors
与核受体结合的内分泌干扰化学物质普查
  • 批准号:
    487142
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Operating Grants
Prenatal endocrine-disrupting chemicals, pandemic-related stress and social risk in mothers and infants
母亲和婴儿的产前内分泌干扰化学物质、流行病相关压力和社会风险
  • 批准号:
    10573800
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
Health Impacts of Pre-Conception and Early Childhood Exposure to Endocrine Disrupting Chemicals
受孕前和儿童早期接触内分泌干扰化学物质对健康的影响
  • 批准号:
    480817
  • 财政年份:
    2023
  • 资助金额:
    $ 9.92万
  • 项目类别:
    Miscellaneous Programs
Assessing the accuracy of exposure measurements for common endocrine disrupting chemicals
评估常见内分泌干扰化学品暴露测量的准确性
  • 批准号:
    10508301
  • 财政年份:
    2022
  • 资助金额:
    $ 9.92万
  • 项目类别:
Assessing the accuracy of exposure measurements for common endocrine disrupting chemicals
评估常见内分泌干扰化学品暴露测量的准确性
  • 批准号:
    10697328
  • 财政年份:
    2022
  • 资助金额:
    $ 9.92万
  • 项目类别:
A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort
个性化数字干预计划,以减少育龄人群接触内分泌干扰化学物质的机会
  • 批准号:
    10699889
  • 财政年份:
    2022
  • 资助金额:
    $ 9.92万
  • 项目类别:
Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals (EDCs) in Women of Child-Bearing Age and their Partners
个性化移动干预减少育龄妇女及其伴侣接触内分泌干扰化学物质 (EDC)
  • 批准号:
    10484791
  • 财政年份:
    2022
  • 资助金额:
    $ 9.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了